269 related articles for article (PubMed ID: 3354621)
21. New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion.
Di Pietro V; Cavallari U; Amorini AM; Lazzarino G; Longo S; Poggiani C; Cavalli P; Tavazzi B
Clin Biochem; 2013 Dec; 46(18):1902-4. PubMed ID: 24036223
[TBL] [Abstract][Full Text] [Related]
22. Stable isotope dilution analysis of N-acetylaspartic acid in CSF, blood, urine and amniotic fluid: accurate postnatal diagnosis and the potential for prenatal diagnosis of Canavan disease.
Jakobs C; ten Brink HJ; Langelaar SA; Zee T; Stellaard F; Macek M; Srsnová K; Srsen S; Kleijer WJ
J Inherit Metab Dis; 1991; 14(5):653-60. PubMed ID: 1779610
[TBL] [Abstract][Full Text] [Related]
23. N-acetylaspartic aciduria in young age.
Elpeleg ON
Neuropediatrics; 1992 Apr; 23(2):112. PubMed ID: 1603285
[No Abstract] [Full Text] [Related]
24. Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism.
Tavazzi B; Lazzarino G; Leone P; Amorini AM; Bellia F; Janson CG; Di Pietro V; Ceccarelli L; Donzelli S; Francis JS; Giardina B
Clin Biochem; 2005 Nov; 38(11):997-1008. PubMed ID: 16139832
[TBL] [Abstract][Full Text] [Related]
25. [Canavan disease (aspartoacylase deficiency)].
Kobayashi K; Tsujino S
Ryoikibetsu Shokogun Shirizu; 2001; (36):118-21. PubMed ID: 11596340
[No Abstract] [Full Text] [Related]
26. Canavan disease: a review of recent developments.
Gordon N
Eur J Paediatr Neurol; 2001; 5(2):65-9. PubMed ID: 11589315
[TBL] [Abstract][Full Text] [Related]
27. Mild elevation of N-acetylaspartic acid and macrocephaly: diagnostic problem.
Surendran S; Bamforth FJ; Chan A; Tyring SK; Goodman SI; Matalon R
J Child Neurol; 2003 Nov; 18(11):809-12. PubMed ID: 14696913
[TBL] [Abstract][Full Text] [Related]
28. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ
Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
[TBL] [Abstract][Full Text] [Related]
29. [Organic aciduria in Canavan disease].
Elpeleg ON; Amir N; Glick B; Gross-Tzur V; Zelnik N; Tamiri Z
Harefuah; 1989 Dec; 117(11):366-8. PubMed ID: 2620877
[TBL] [Abstract][Full Text] [Related]
30. Biochemical heterogeneity of infantile central nervous system spongy degeneration.
Subramanyam SB; Tipirneni A; Youssef N; Gascon GG; Ozand PT
J Child Neurol; 1992 Apr; 7 Suppl():S22-5. PubMed ID: 1588011
[TBL] [Abstract][Full Text] [Related]
31. Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis.
Elpeleg ON; Shaag A; Anikster Y; Jakobs C
J Inherit Metab Dis; 1994; 17(6):664-6. PubMed ID: 7707689
[TBL] [Abstract][Full Text] [Related]
32. A mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
Eke GH; Iscan A; Cece H; Calik M
Genet Couns; 2012; 23(1):9-12. PubMed ID: 22611636
[TBL] [Abstract][Full Text] [Related]
33. Purification, characterization, and localization of aspartoacylase from bovine brain.
Kaul R; Casanova J; Johnson AB; Tang P; Matalon R
J Neurochem; 1991 Jan; 56(1):129-35. PubMed ID: 1987315
[TBL] [Abstract][Full Text] [Related]
34. Possible genotype-phenotype correlations in children with mild clinical course of Canavan disease.
Tacke U; Olbrich H; Sass JO; Fekete A; Horvath J; Ziyeh S; Kleijer WJ; Rolland MO; Fisher S; Payne S; Vargiami E; Zafeiriou DI; Omran H
Neuropediatrics; 2005 Aug; 36(4):252-5. PubMed ID: 16138249
[TBL] [Abstract][Full Text] [Related]
35. A case of Canavan disease: the first biochemically proven case in a Japanese girl.
Hamaguchi H; Nihei K; Nakamoto N; Ezoe T; Naito H; Hara M; Yokota K; Inoue Y; Matsumoto I
Brain Dev; 1993; 15(5):367-71. PubMed ID: 8279652
[TBL] [Abstract][Full Text] [Related]
36. Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings.
Zafeiriou DI; Kleijer WJ; Maroupoulos G; Anastasiou AL; Augoustidou-Savvopoulou P; Papadopoulou F; Kontopoulos EE; Fagan E; Payne S
Brain Dev; 1999 Apr; 21(3):205-8. PubMed ID: 10372908
[TBL] [Abstract][Full Text] [Related]
37. [Megalencephaly with dystonia revealing Canavan disease].
Maaloul I; Fourati H; Wali M; Chabchoub I; Kamoun T; Mnif Z; Kaabachi N; Hachicha M
Arch Pediatr; 2013 Jul; 20(7):783-6. PubMed ID: 23727372
[TBL] [Abstract][Full Text] [Related]
38. Knock-out mouse for Canavan disease: a model for gene transfer to the central nervous system.
Matalon R; Rady PL; Platt KA; Skinner HB; Quast MJ; Campbell GA; Matalon K; Ceci JD; Tyring SK; Nehls M; Surendran S; Wei J; Ezell EL; Szucs S
J Gene Med; 2000; 2(3):165-75. PubMed ID: 10894262
[TBL] [Abstract][Full Text] [Related]
39. NMR spectroscopy of aminoacylase 1 deficiency, a novel inborn error of metabolism.
Engelke UF; Sass JO; Van Coster RN; Gerlo E; Olbrich H; Krywawych S; Calvin J; Hart C; Omran H; Wevers RA
NMR Biomed; 2008 Feb; 21(2):138-47. PubMed ID: 17516490
[TBL] [Abstract][Full Text] [Related]
40. The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients.
Elpeleg ON; Shaag A
J Inherit Metab Dis; 1999 Jun; 22(4):531-4. PubMed ID: 10407784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
